Vimarsana
Biggest News Aggregation in the World

Deimos Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deimos Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deimos Bioscience Today - Breaking & Trending Today

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses - Vimarsana News

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses

Published: May 22, 2024

- Jupiter Bioventures will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib for Radioprotection in the US, Europe, Japan, and All Other...

Source: marketscreener.com
Related Topics:
Jupiter BioventuresDavid ButtaroJack BaileyGenor BiopharmaNathaniel DavidGain Exclusive Rights For The Clinical DevelopmentResearch Triangle ParkExchange CommissionTherapeutics IncNational Medical Products AdministrationCorporate CommunicationsGain Exclusive RightsClinical DevelopmentRegulatory SubmissionsDeimos BiosciencesManaging DirectorPepper BioDeimos BioscienceChief Executive OfficerPrivate Securities Litigation Reform ActBioventures ContactInvestor Relations
G1 Therapeutics And Deimos Biosciences In License Deal For Lerociclib For Radioprotective Uses - Vimarsana News

G1 Therapeutics And Deimos Biosciences In License Deal For Lerociclib For Radioprotective Uses

Published: May 22, 2024

(RTTNews) - G1 Therapeutics, Inc. (GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures,...

Source: businessinsider.com
Related Topics:
Genor BiopharmaJupiter BioventuresTherapeutics IncNational Medical Products AdministrationDeimos BiosciencesDeimos BiosciencePepper Bio